New insulin pump aims to tame blood sugar swings

NCT ID NCT07579702

First seen Jun 26, 2026 · Last updated Aug 04, 2026 · Updated 4 times

Summary

This study compares a new insulin pump system, Omnipod 6, to the current Omnipod 5 in 200 people with type 1 or type 2 diabetes who have poor blood sugar control. Participants will use both pumps for a set time to see which one helps keep blood sugar in a healthy range more effectively and reduces dangerous lows. The goal is to find out if the upgraded system offers real benefits for daily diabetes management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Omnipod 6 insulin pump system
What this could lead to
If it works, this could mean better blood sugar control and fewer dangerous lows for people with diabetes using an insulin pump.
What could go wrong
This is an early comparison study with only 200 participants, so results may not apply to everyone. The new pump might not show a meaningful improvement over the current model.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Baylor College of Medicine

    RECRUITING

    Houston, Texas, 77030, United States

  • Emory University

    RECRUITING

    Atlanta, Georgia, 30308, United States

  • Health Partners

    RECRUITING

    Minneapolis, Minnesota, 55416, United States

  • Henry Ford Health Systems

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Indiana University

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Joslin Diabetes Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Northwestern University

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Sansum Diabetes Research Institute

    RECRUITING

    Santa Barbara, California, 93105, United States

  • University of Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Southern California

    RECRUITING

    Los Angeles, California, 90022, United States

  • Yale

    RECRUITING

    New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.